Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2018, Article ID 1720725, 3 pages
https://doi.org/10.1155/2018/1720725
Case Report

Ischemic Stroke: Do Not Forget Lyme Neuroborreliosis

Division of Neurorehabilitation, Geneva University Hospitals, Geneva, Switzerland

Correspondence should be addressed to Gabriela Moreno Legast; hc.eguch@onerom.aleirbag

Received 21 November 2017; Revised 1 February 2018; Accepted 26 February 2018; Published 1 April 2018

Academic Editor: Chin-Chang Huang

Copyright © 2018 Gabriela Moreno Legast et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. T. Borchers, C. L. Keen, A. C. Huntley, and M. E. Gershwin, “Lyme disease: a rigorous review of diagnostic criteria and treatment,” Journal of Autoimmunity, vol. 57, pp. 82–115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Wittwer, S. Pelletier, X. Ducrocq, L. Maillard, G. Mione, and S. Richard, “Cerebrovascular events in Lyme neuroborreliosis,” Journal of Stroke and Cerebrovascular Diseases, vol. 24, no. 7, pp. 1671–1678, 2015. View at Publisher · View at Google Scholar
  3. A. Garkowski, J. Zajkowska, A. Zajkowska et al., “Cerebrovascular manifestations of lyme neuroborreliosis-A systematic review of published cases,” Frontiers in Neurology, vol. 8, p. 146, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Sokolov, R. Lienhard, R. Du Pasquier, and V. Erard, “Acute Lyme neuroborreliosis with transient hemiparesis and aphasia,” Annals of Emergency Medicine, vol. 66, no. 1, pp. 60–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Asherson and R. Cervera, “Antiphospholipid antibodies and infections,” Annals of the Rheumatic Diseases, vol. 62, no. 5, pp. 388–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. P. Greco, A. M. Conti-Kelly, and T. P. Greco, “Antiphospholipid antibodies in patients with purported 'chronic Lyme disease',” Lupus, vol. 20, no. 13, pp. 1372–1377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Shoenfeld, M. Blank, R. Cervera, J. Font, E. Raschi, and P.-L. Meroni, “Infectious origin of the antiphospholipid syndrome,” Annals of the Rheumatic Diseases, vol. 65, no. 1, pp. 2–6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Mygland, U. Ljøstad, V. Fingerle, T. Rupprecht, E. Schmutzhard, and I. Steiner, “EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis,” European Journal of Neurology, vol. 17, no. 1, pp. e1–e4, 2010. View at Publisher · View at Google Scholar
  9. R. Dersch, H. Sommer, S. Rauer, and J. J. Meerpohl, “Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review,” Journal of Neurology, vol. 263, no. 1, pp. 17–24, 2016. View at Publisher · View at Google Scholar · View at Scopus